Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II
- 1 December 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 21 (12) , 2335-2344
- https://doi.org/10.1097/00004872-200312000-00023
Abstract
To investigate whether superoxide mediates angiotensin (Ang) II-induced vasoconstriction. Human coronary arteries (HCAs), porcine femoral arteries (PFA) and porcine coronary arteries (PCAs) were mounted in organ baths and concentration-response curves to Ang II, the nitric oxide (NO) donor S-nitroso-N-acetylpenicillamine (SNAP) and the NAD(P)H oxidase substrate NADH were constructed in the absence and presence of superoxide inhibiting and activating drugs. Extracellular superoxide was measured using cytochrome c reduction. Ang II constricted both HCAs and PFAs. In HCAs, the NAD(P)H inhibitors diphenyleneiodonium (DPI) and apocynin, and the xanthine oxidase (XO) inhibitor allopurinol, but not the superoxide dismutase (SOD) mimetic tempol or the SOD inhibitor diethyldithiocarbamate (DETCA), reduced this constriction. Catalase potentiated Ang II in HCAs, indicating a vasodilator role for H2O2. DPI, tempol and SOD did not affect Ang II in PFAs. DPI, apocynin and allopurinol relaxed preconstricted HCAs. Although the relaxant effects of the NO donor SNAP in PCAs was reduced by DETCA, indicating that superoxide-induced constrictions depend on NO inactivation, the apocynin-induced relaxations were NO independent. Moreover, NADH relaxed all vessels, and this effect was blocked by KCl but not DPI or NO removal. Xanthine plus XO also relaxed HCAs and PCAs. Incubation of human or porcine arteries with Ang II or NADH did not result in detectable increases of extracellular superoxide within 1 h. Acute vasoconstriction by Ang II is not mediated via superoxide generated through NAD(P)H oxidase and/or XO activation. Such activation, if occurring, rather results in the generation of the vasodilator H2O2.Keywords
This publication has 38 references indexed in Scilit:
- Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Modulation by hydrogen peroxide of noradrenaline-induced contraction in aorta from streptozotocin-induced diabetic ratEuropean Journal of Pharmacology, 2002
- Role of NADPH Oxidase in the Vascular Hypertrophic and Oxidative Stress Response to Angiotensin II in MiceCirculation Research, 2001
- Investigation Into the Sources of Superoxide in Human Blood VesselsCirculation, 2000
- Blood Pressure–Independent Effects in Rats With Human Renin and Angiotensinogen GenesHypertension, 2000
- Ang II–Stimulated Superoxide Production Is Mediated via Phospholipase D in Human Vascular Smooth Muscle CellsHypertension, 1999
- Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin IIProceedings of the National Academy of Sciences, 1997
- Role of Superoxide in Angiotensin II–Induced but Not Catecholamine-Induced HypertensionCirculation, 1997
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.Journal of Clinical Investigation, 1996
- Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.Circulation Research, 1994